Salary Growth Outpaces Hourly Wages What It Signals for the Labor Market Traders on Kalshi Predict US Government May Target IonQ Micron Anduril as Next Equity Stakes Singapore Upgrades 2026 Export Growth Forecast on Surging AI Demand Mercury Fintech Hits 52 Billion Valuation After Funding Round Surging 49 in 14 Months Vegorama Punjabi Angithi IPO Allotment Expected Today May 25 Subscription at 35 Times BHP Acknowledges Emissions Reduction Delays Amid WA Premiers Call for Miner Decarbonisation AMBR Q4 2025 Earnings Modest EPS Miss Meets Positive Stock Momentum AA Q1 2026 Earnings EPS Misses Estimates Shares Rise Amid Operational Resilience MDWD Q4 2025 Earnings Narrower Loss Beats Estimates as Operational Focus Continues Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Execution Alignment Healthcare ALHC Holds Near Key Support After Modest Decline ACP Edges Higher in LowVolume Trading Consolidates Near Resistance Logitech LOGI Slips Slightly Support Test Looms Near 10475 KE Holdings BEKE Edges Higher as Stock Holds Near Support Shenandoah Telecommunications SHEN Slips 155 as Stock Tests Key Support Levels Inflations Impact on Savings Understanding the Rate to Beat PASG Q1 2026 Earnings Narrowerthanexpected loss lifts shares Eaton Corporation ETN Gains Momentum Technical and Fundamental Drivers Behind the Uptrend Shift4 Payments Q1 2026 Earnings EPS Miss Slightly Offset by Resilient Share Performance GFS Q1 2026 Earnings Earnings Beat Expectations on EPS Shares Rise GATX Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Railcar Leasing Demand Envoy Medical Inc COCH Q1 2026 Earnings Strong EPS Beat Amidst PreRevenue Stage STAA Q1 2026 Earnings Strong EPS Surprise of 45385 Driven by Operational Efficiency Emergent BioSolutions Q1 2026 Earnings EPS Surprise of 183 as the Company Returns to Profitability FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech